Allianz Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.12M Buy
158,871
+23,185
+17% +$858K 0.01% 1150
2025
Q4
$5.71M Buy
135,686
+1,589
+1% +$64.1K 0.01% 1073
2025
Q3
$4.6M Buy
134,097
+46,573
+53% +$1.34M 0.01% 1147
2025
Q2
$2.37M Buy
87,524
+8,214
+10% +$238K ﹤0.01% 1426
2025
Q1
$2.35M Buy
79,310
+900
+1% +$34.3K ﹤0.01% 1438
2024
Q4
$3.11M Buy
78,410
+71,710
+1,070% +$2.72M ﹤0.01% 1246
2024
Q3
$228K Buy
+6,700
New +$188K ﹤0.01% 2052
2021
Q2
Sell
-62,233
Closed -$3.35M 2489
2021
Q1
$3.35M Sell
62,233
-49,801
-44% -$2.87M ﹤0.01% 1213
2020
Q4
$5.48M Buy
112,034
+19,771
+21% +$916K 0.01% 1016
2020
Q3
$3M Sell
92,263
-260,438
-74% -$8.28M ﹤0.01% 1128
2020
Q2
$9.13M Sell
352,701
-156,837
-31% -$3.91M 0.01% 936
2020
Q1
$12.4M Buy
509,538
+1,806
+0.4% +$45.5K 0.02% 757
2019
Q4
$14.2M Buy
507,732
+32,361
+7% +$838K 0.01% 952
2019
Q3
$11.4M Sell
475,371
-22,372
-4% -$595K 0.01% 1040
2019
Q2
$14.2M Sell
497,743
-82,192
-14% -$2.05M 0.01% 991
2019
Q1
$14.5M Sell
579,935
-64,323
-10% -$1.23M 0.01% 915
2018
Q4
$8.11M Buy
644,258
+6,412
+1% +$75.8K 0.01% 1213
2018
Q3
$6.09M Buy
637,846
+446,817
+234% +$4.93M 0.01% 1475
2018
Q2
$1.78M Buy
+191,029
New +$1.34M ﹤0.01% 1994

Other funds holding VCYT

Allianz Asset Management's VCYT Position: Q1 2026 in Review

Allianz Asset Management increased its Veracyte (VCYT) stake by 17% in Q1 2026, buying an estimated $858K and bringing the position to 158,871 shares worth $5.12M. The position accounts for 0.01% of the portfolio, ranked #1150.

Allianz Asset Management first reported a position in VCYT in Q2 2018 and has held it in 19 quarters since. The position peaked at $14.5M in Q1 2019. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Allianz Asset Management held 158,871 shares of Veracyte worth $5.12M as of Q1 2026.
  • Allianz Asset Management bought 23,185 Veracyte shares in Q1 2026, an estimated $858K.
  • Veracyte made up 0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1150 holding.
  • Allianz Asset Management first reported a position in Veracyte in Q2 2018 and has held it in 19 quarters since.
  • Allianz Asset Management's Veracyte position peaked at $14.5M in Q1 2019.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.